Navigation Links
Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and Multiple Molecular Targets
Date:10/7/2010

Non-Small Cell Lung Cancer (NSCLC).  Poster Discussion. Sunday, October 10: 12:30. David Ross Camidge - Presenter. 35th Congress of the European Society for Medical Oncology. Milan, Italy. October 8 - 12, 2010.  

(5)  ESMO Accepted Abstract # LBA6. Sunitinib (SU) in combination with erlotinib (E) for the treatment of advanced/metastatic non-small cell lung cancer (NSCLC): a phase III study. Proferred Paper. Monday, October 11: 10:30-10:45. Giorgio V Scagliotti - Presenter. 35th Congress of the European Society for Medical Oncology. Milan, Italy. October 8 - 12, 2010.  

(6)  ESMO Accepted Abstract #747P. Evaluation of progression-free survival (PFS) by blinded independent central review (BICR) in patients (pts) with progressive, well-differentiated pancreatic neuroendocrine tumours (NET) treated with sunitinib (SU) or placebo. Poster Presentation. Saturday, October 9: 13:00-14:00. Eric van Cutsem - Presenter. 35th Congress of the European Society for Medical Oncology. Milan, Italy. October 8 - 12, 2010.  

(7)  ESMO Accepted Abstract #1344O. Safety and Efficacy Results from a Phase 1/2 Study of the Anti-IGF-IR Antibody Figitumumab in Patients with Refractory Ewing's and Other Sarcomas. Proferred Paper. Sunday, October 10: 9:15-9:30. Heribert Juergens - Presenter. 35th Congress of the European Society for Medical Oncology. Milan, Italy. October 8 - 12, 2010.  

(8)  ESMO Accepted Abstract #213O. Distant recurrences at median of 5-years among 9.779 postmenopausal women with hormone receptor-positive early breast cancer treated on the TEAM trial of adjuvant endocrine therapy. Proffered Paper.  Monday, October 11: 9:00-9:15. Hans Nortier - Presenter. 35th Congress of the European Society for Medical Oncology. Milan, Italy. October 8 - 12, 2010.  

(9)  ESMO Accepted Abstract #225P. Effects of exemestane or tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Mult
'/>"/>

SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
3. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
4. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
5. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
6. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
7. MannKind Addresses Pfizers Announcement Regarding Exubera
8. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
9. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
10. Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing
11. Pfizer Contributes Critical Data to URMC Drug Safety Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... CLARA, Calif. , May 21, 2013 ... game-changing embedded-ultrasound platform, today announced the introduction ... that allows complete network-based communications with all ... its latest embedded-ultrasound technology, including this new ... Sao Paulo, Brazil from ...
(Date:5/21/2013)...  Vasomedical, Inc. (OTC BB: VASO) (the "Company"), a diversified ... of medical devices and in the domestic sale of diagnostic ... , President and CEO of Vasomedical, Inc. will present ... May 30, 2013 in New York City ... Company,s presentation is scheduled to begin at 9:30 a.m. EDT. ...
(Date:5/21/2013)... Calif. , May 21, 2013   ... announced today the publication of study results involving ... CyberKnife® Robotic Radiosurgery System, the most widely used ... The study followed 304 patients for a median ... post-treatment and found that 97 percent of patients ...
Breaking Medicine Technology:Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms 2Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3
... THE WOODLANDS, Texas, Dec. 6, 2011 The US Oncology ... M.D., New York Oncology Hematology , and J. Russell ... discussion with oncologists on value-based reimbursement and its impact on the ... Dec. 13 at 1:00 p.m. ET/ 12 p.m. CT/ 11 a.m. ...
... and AMSTERDAM, Dec. 6, 2011 Agendia, an ... of formalin fixed, paraffin embedded tissue technology applied ... Delivering Agendia,s tests in a paraffin embedded tissue ... the superior science, development and validation found in ...
Cached Medicine Technology:The US Oncology Network to Present Webinar on Value-Based Reimbursement 2Agendia Introduces the SYMPHONY™ Breast Cancer Profile With Paraffin Embedded Tissue 2
(Date:5/21/2013)... Antonio, TX (PRWEB) May 21, 2013 ... from the Texas Department of Aging and Disability Services. ... visits and employee interviews, ContinuCare Home Health was ... , The review is part of the Department of ... array of aging and disability services, supports and ...
(Date:5/21/2013)... CA (PRWEB) May 21, 2013 ... Annual EB-5 Investment Summit: Dealmakers Conference in Long ... Conference will focus on exploring alternative finance through ... the latest market, legal and economic information, and ... and legal professionals within the EB-5 industry. ...
(Date:5/21/2013)... According to a May 13, 2013 New ... Botox,” Botox injections have become the most popular ... (Go to goo.gl/8iYbD). Although it is mostly associated with women, ... injection makes facial wrinkles less visible by paralyzing facial muscles. ... three months. This means that people who are conscious about ...
(Date:5/21/2013)... Diversity Focus, a non-profit organization striving to ... in the Creative Corridor region, is releasing results for ... conference on Thursday, May 23rd at 10:30 a.m. ... , The survey is a critical component ... that attract, nurture and retain people of diverse backgrounds, ...
(Date:5/21/2013)... A paper recently published in the New England ... scientists at the University of Colorado School of Medicine ... fibrosis can be used to identify individuals at risk ... a fairly common variant of the gene for mucin-5B, ... produced by the bronchial tubes. While this variant of ...
Breaking Medicine News(10 mins):Health News:ContinuCare Home Health, Inc. Receives Perfect Report from the Texas Department of Aging and Disability Services 2Health News:Artisan Business Group to Host EB-5 Investment Conference in Long Beach, California 2Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2Health News:Researchers find genetic risk factor for pulmonary fibrosis 2
... experts say , TUESDAY, Dec. 29 (HealthDay News) -- Winter,s ... but they pose extra hazards for elderly people, experts say. ... adults over age 65 in the United States. Some 1.8 ... departments for falls in 2005, and 15,800 died from their ...
... , ... System and Robert Gerson, MD, Board Certified Plastic Surgeon, will be offering free cosmetic ... ... Health System and Robert Gerson, MD, Board Certified Plastic Surgeon, will be offering free ...
... YORK, Dec. 29 Nutritionist Judy Pentra, of Patients Medical , ... can be a vulnerable time for people trying to lose weight and ... holidays and many resolve to lose the weight in January, however, 70 ... of the biggest problems for busy executives trying to get in shape ...
... N.Y. -- The role of pharmacists hasn,t received much ... care. But national and regional studies show that when ... treatment costs and improve outcomes. A study on diabetic ... and Pharmaceutical Sciences identified cost savings with improvements in ...
... , Michigan Business and Professional Association ... Dec. 29 Eighty-three percent of the owners of small ... care plan as a public option for insurance, according to ... Business and Professional Association (MBPA) and the Michigan ...
... , , SAN JOSE, Calif. , ... 2009 a year of success in advocacy, research support and ... PF is a fatal disease that has no known cause, ... grassroots fundraising efforts in 2009, further advancing the effort to ...
Cached Medicine News:Health News:Caution Can Help Keep Elderly Safe During Winter 2Health News:Patients Medical Warns Against The Manhattan Diet 2Health News:Pharmacists improve care of diabetics while cutting costs, UB research shows 2Health News:Pharmacists improve care of diabetics while cutting costs, UB research shows 3Health News:83 Percent of Small Businesses Say 'No' to Health Care Public Option, 89 Percent Say Government Cannot Provide Adequate Health Care 2Health News:83 Percent of Small Businesses Say 'No' to Health Care Public Option, 89 Percent Say Government Cannot Provide Adequate Health Care 3Health News:Coalition for Pulmonary Fibrosis Celebrates Successes Despite Year of Economic Downturn 2Health News:Coalition for Pulmonary Fibrosis Celebrates Successes Despite Year of Economic Downturn 3Health News:Coalition for Pulmonary Fibrosis Celebrates Successes Despite Year of Economic Downturn 4
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Reusable, stainless steel trephine with handle....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: